Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cells

We performed microarray analysis of peripheral blood mononuclear cells (PBMCs) from multiple sclerosis (MS) patients and detected a profile of immune cell activation, autoantigen upregulation, and enhanced E2F pathway transcription. Accordingly, E2f1-deficient mice manifested only mild disability upon induction of experimental autoimmune encephalomyelitis (EAE). Furthermore, PBMCs from Avonex-treated patients had lower expression of E2F targets. The profile was enriched in genes known to harbor MS-associated polymorphisms, or localized to MS susceptibility chromosomal regions. Our study shows that PBMC microarrays reflect MS pathobiology that can be validated in the EAE model.

[1]  T. Volkert,et al.  E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. , 2002, Genes & development.

[2]  S. Barnum,et al.  Enhanced expression of chemotactic receptors in multiple sclerosis lesions , 1996, Journal of the Neurological Sciences.

[3]  P. Brown,et al.  Exploring the metabolic and genetic control of gene expression on a genomic scale. , 1997, Science.

[4]  B. Williams,et al.  Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .

[5]  G. Stephanopoulos,et al.  A compendium of gene expression in normal human tissues. , 2001, Physiological genomics.

[6]  Jorge R. Oksenberg,et al.  Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.

[7]  C. Sardet,et al.  Activation of E2F-mediated Transcription by Human T-cell Leukemia Virus Type I Tax Protein in a p16 INK4A -negative T-cell Line* , 1998, The Journal of Biological Chemistry.

[8]  J. Bluestone,et al.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. , 1995, Immunity.

[9]  R. Chignola,et al.  Myelin basic protein epitopes secreted by human T cells encounter natural autoantibodies in the serum , 2003, Journal of Neuroimmunology.

[10]  K. Ohtani,et al.  Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I , 2001, Oncogene.

[11]  J. Golaz,et al.  Activated T lymphocytes in patients with multiple sclerosis , 1983, Neurology.

[12]  E. Shevach,et al.  Cbl-b regulates the CD28 dependence of T-cell activation , 2000, Nature.

[13]  Javed Khan,et al.  Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. , 2003, Human molecular genetics.

[14]  M. Greenberg,et al.  Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. , 2001, Immunity.

[15]  L. Ignarro,et al.  Cutting Edge: Antisense Knockdown of Inducible Nitric Oxide Synthase Inhibits Induction of Experimental Autoimmune Encephalomyelitis in SJL/J Mice , 1998, The Journal of Immunology.

[16]  James B. Johnston,et al.  Monocyte activation and differentiation augment human endogenous retrovirus expression: Implications for inflammatory brain diseases , 2001, Annals of neurology.

[17]  C. Koh,et al.  Serum levels of apoptosis-related molecules in patients with multiple sclerosis and human T-lymphotropic virus Type I-associated myelopathy. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[18]  T. Kouzarides,et al.  Regulation of E2F1 activity by acetylation , 2000, The EMBO journal.

[19]  N. Dyson.  The regulation of E2F by pRB-family proteins. , 1998, Genes & development.

[20]  K. Ohtani,et al.  Cell Type-specific E2F Activation and Cell Cycle Progression Induced by the Oncogene Product Tax of Human T-cell Leukemia Virus Type I* , 2000, The Journal of Biological Chemistry.

[21]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  David H. Miller,et al.  A controlled trial of natalizumab for relapsing multiple sclerosis. , 2003, The New England journal of medicine.

[23]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Hjelmström,et al.  A Critical Role for Lymphotoxin in Experimental Allergic Encephalomyelitis , 1997, The Journal of experimental medicine.

[25]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[26]  R. Slack,et al.  The Transcription Factor E2F1 Modulates Apoptosis of Neurons , 2000, Journal of neurochemistry.

[27]  J. DeGregori,et al.  Defective Gene Expression, S Phase Progression, and Maturation during Hematopoiesis in E2F1/E2F2 Mutant Mice , 2003, Molecular and Cellular Biology.

[28]  F. Barkhof,et al.  Multiple sclerosis , 2003, Neurology.

[29]  L. Staudt,et al.  Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis. , 2003, Brain : a journal of neurology.

[30]  Virginia Pascual,et al.  Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.

[31]  J. Nevins,et al.  The E2F1–3 transcription factors are essential for cellular proliferation , 2001, Nature.

[32]  M. Kotze,et al.  Analysis of the NRAMP1 gene implicated in iron transport: association with multiple sclerosis and age effects. , 2001, Blood cells, molecules & diseases.

[33]  C. McKerlie,et al.  T Cells of Multiple Sclerosis Patients Target a Common Environmental Peptide that Causes Encephalitis in Mice1 , 2001, The Journal of Immunology.

[34]  A. Cross,et al.  Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. , 1997, Journal of immunology.

[35]  J. Haines,et al.  Multiple susceptibility loci for multiple sclerosis. , 2002, Human molecular genetics.

[36]  D Spiegelman,et al.  Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. , 2001, JAMA.

[37]  Yihong Ma,et al.  Identification of novel E2F1-regulated genes by microarray. , 2002, Archives of biochemistry and biophysics.

[38]  B. Groner,et al.  Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. , 1997, Immunity.

[39]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[40]  H. Andersen,et al.  Is multiple sclerosis caused by a dual infection with retrovirus and Epstein-Barr virus? , 1992, Neuroepidemiology.

[41]  J. Auwerx,et al.  E2Fs regulate adipocyte differentiation. , 2002, Developmental cell.